Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue 3, 1996, Pages 255-259

  Yamazaki, Masahide ^a   Asakura, Hidesaku ^b   Aoshima, Keiji ^b   Saito, Masanori ^b   Jokaji, Hiroshi ^b   Uotani, Chika ^b   Kumabashiri, Ichiro ^b   Morishita, Eriko ^b   Ikeda, Takayuki ^b   Matsuda, Tamotsu ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Antithrombotic drug; DX 9065a; Factor Xa inhibitor; Rats; Thromboplastin induced DIC model

Indexed keywords

2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RAT; THROMBOCYTE COUNT;

EID: 8944246792     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-999016     Document Type: Article

References (13)

1. McKay DG: Disseminated Intravascular Coagulation. Harper & Row, New York, 1965.
2. Hamilton PJ, AL Stalker, AS Douglas: Disseminated intravascular coagulation: A review. J Clin Pathol 31:609-619, 1978.
3. Nordstoga K: Disseminated intravascular coagulation: A pathologist's view. (Letter): Thromb Haemostas 37:180, 1977.
4. Asakura H, H Jokaji, M Saito, C Uotani, I Kumabashiri, E Morishita, M Yamazaki, T Matsuda: Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation. Am J Hematol 36:176-183, 1991.
5. Hara T, A Yokoyama, H Ishihara, Y Yokoyama, T Nagahara, M Iwamoto: DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa. Thromb Haemostas 71:314-319, 1994.
6. Yamazaki M, H Asakura, K Aoshima, M Saito, H Jokaji, C Uotani, I Kumabashiri, E Morishita, T Ikeda, T Matsuda: Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats. Thromb Haemostas 72:393-396, 1994.
7. Ferreira HC, LG Murat: Immunological method for demonstrating fibrin degradation products in serum and its use in the diagnosis of fibrinolytic states. Br J Haematol 9:299-310, 1963.
8. Goodwin JF: Estimation of plasma fibrin using sodium sulfate fractionation. Am J Clin Pathol 35:227-232, 1961.
9. Pelzer H, A Schwarz, N Heimburger: Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemostas 59:101-106, 1988.
10. Quick AJ, M Stanly-Brown, FW Bancroft: A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 190:501-511, 1935.
11. Langwell RD, RH Wagner, KM Brinkhouse: Effect of antihemophilic factor on one-stage clotting time. J Lab Clin Med 47:637-647, 1953.
12. Weigert C: Über eine neue Methode zur Färbung von Fibrin und von Microorganismen. Fortschr Med 5:228-237, 1987.
13. Hara T, S Kunitada, M Iwamoto: DX-9065a, a synthetic and selective factor Xa inhibitor; species difference in its anticoagulant activity. (Abst.) Thromb Haemostas 69:890, 1993.